BTAIQ
BioXcel Therapeutics, Inc.Healthcare · Drug Manufacturers - Specialty & Generic
$231.01 sample
+1.38 (+0.60%) 1D
Market cap
$510.6B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-12
Alerts
8
Price$231.01 +25.66% 3M daily closessample
233.26183.73
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 21INS
- Oct 12SEC
- Oct 07SEC
- Sep 30INS
- Sep 22SEC
- Sep 14INS
- Sep 04INS
- Sep 01INS
Company facts
SEC EDGAR registration- Name
- BioXcel Therapeutics, Inc.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Smart-money score
- +13sample, -100 to +100
- Reporting currency
- USD
Who is positioning in BTAIQ
sample- Insiders
- 19 insider transactions over 90 days, net selling, $584.9M
- Congress
- 1 members traded over 90 days
- Institutions · 13F
- 9 funds hold $12.1B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$20.2B +17.7% y/y
Q4 2024Q3 2026
Inventory$12.7B +13.2% y/y
Q4 2024Q3 2026
Accounts receivable$9.0B +14.1% y/y
Q4 2024Q3 2026
Total debt$25.5B +17.7% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $373.1B -8.5% 3M
- Sample peer B
- $237.9B +15.3% 3M
- Sample peer C
- $497.1B +12.3% 3M
- Sample peer D
- $83.0B +7.0% 3M
- Sample peer E
- $414.3B +9.8% 3M